Compare Okta, Inc. (OKTA) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Okta, Inc. vs UnitedHealth Group Inc — how do they compare? Okta, Inc. trades at $136.51 (market cap $24.63B), while UnitedHealth Group Inc trades at $431.76 (market cap $396.27B). The key difference: UnitedHealth Group Inc is far larger — about 16.1× Okta, Inc.'s market cap, and UnitedHealth Group Inc pays a 2.13% dividend while Okta, Inc. pays none. Which is the better fit depends on your goals.
| OKTA | UNH | |
|---|---|---|
Market Cap | $24.63B | $396.27B |
Sector | Technology | Health |
52-Week High | $154.62 | $436.35 |
52-Week Low | $62.93 | $237.77 |
Enterprise Value | $22.45B | $442.96B |
Dividend Yield | — | 2.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OKTA trades at $141.63, down 5.17% in the last session amid broader market volatility. The stock shows strong fundamental improvement with revenue growing to $2.61B in 2025 and achieving positive net income of $28M after years of losses. Technical indicators suggest a bullish trend with strong moving average signals, while oscillators remain neutral. Recent analyst coverage remains overwhelmingly positive with 37 buy ratings versus 2 sell ratings.
The outlook remains constructive given OKTA's position in the growing cybersecurity sector and improving profitability. Key risks include high valuation multiples (P/E of 107.54) and competitive pressures. The consensus price target of $127.96 suggests potential downside from current levels, though the high target of $175.00 indicates significant upside potential if execution continues.
UnitedHealth Group (UNH) trades at $421.55, down 1.07% on the day, with a bullish technical outlook supported by moving averages and ADX signals. The company reported strong Q2 2026 EPS of $6.38, beating estimates, and maintains robust cash flow generation. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns through dividends and buybacks.
UNH presents a favorable investment case with 82.7% analyst buy ratings and a $476.50 consensus price target, implying 13% upside. Risks include regulatory scrutiny from lawsuits and Medicaid fraud allegations, while demographic trends and operational efficiency support long-term growth. The stock's valuation at a P/E of 31.74 reflects premium pricing relative to historical margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
